Higher-dose PPIs (omeprazole 40mg, esomeprazole 40mg) taken once or twice daily can suppress acid production by up to 90%
This makes splitting straightforward, at least mechanically
alternatives: rifaximin, norfloxacin + metronidazole, ciprofloxacin, octreotide Adjunctive Measures Probiotics ( S
The peptide enhances growth factor expression including fibroblast growth factor (FGF) and epidermal growth factor (EGF), while simultaneously reducing pro-inflammatory cytokines like TNF- and IL-6
Known as a fluting iron, this weeks Whats New Wednesday comes from the Shepard Hardware Company
So if retatrutides phase 3 trials finish in 2025 or early 2026, approval and market availability by late 2026 or 2027 is a plausible target assuming all goes well